Следене
Amit Mahipal
Amit Mahipal
University Hospitals Seidman Cancer Center/Case Western Reserve University
Потвърден имейл адрес: uhhospitals.org
Заглавие
Позовавания
Позовавания
Година
Antitumor activity of pembrolizumab in biomarker-unselected patients with recurrent and/or metastatic head and neck squamous cell carcinoma: results from the phase Ib KEYNOTE …
LQM Chow, R Haddad, S Gupta, A Mahipal, R Mehra, M Tahara, R Berger, ...
Journal of Clinical Oncology 34 (32), 3838, 2016
8432016
Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study
MS Lee, BY Ryoo, CH Hsu, K Numata, S Stein, W Verret, SP Hack, ...
The Lancet Oncology 21 (6), 808-820, 2020
4192020
A phase 2 multi-institutional study of nivolumab for patients with advanced refractory biliary tract cancer
RD Kim, V Chung, OB Alese, BF El-Rayes, D Li, TE Al-Toubah, MJ Schell, ...
JAMA oncology 6 (6), 888-894, 2020
3562020
Factors predicting response, perioperative outcomes, and survival following total neoadjuvant therapy for borderline/locally advanced pancreatic cancer
MJ Truty, ML Kendrick, DM Nagorney, RL Smoot, SP Cleary, RP Graham, ...
Annals of surgery 273 (2), 341-349, 2021
3332021
First-in-class, first-in-human phase I study of selinexor, a selective inhibitor of nuclear export, in patients with advanced solid tumors
ARA Razak, M Mau-Soerensen, NY Gabrail, JF Gerecitano, AF Shields, ...
Journal of Clinical Oncology 34 (34), 4142, 2016
2192016
Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic BRAF-Mutant Melanoma
JP Delord, C Robert, M Nyakas, GA McArthur, R Kudchakar, A Mahipal, ...
Clinical Cancer Research 23 (18), 5339-5348, 2017
1742017
Participation of the elderly population in clinical trials: barriers and solutions
AC Denson, A Mahipal
Cancer Control 21 (3), 209-214, 2014
1652014
Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma
L Goyal, F Meric-Bernstam, A Hollebecque, JW Valle, C Morizane, ...
New England Journal of Medicine 388 (3), 228-239, 2023
1592023
Systemic therapy and sequencing options in advanced hepatocellular carcinoma: a systematic review and network meta-analysis
MB Sonbol, IB Riaz, SAA Naqvi, DR Almquist, S Mina, J Almasri, S Shah, ...
JAMA oncology 6 (12), e204930-e204930, 2020
1512020
Importins and exportins as therapeutic targets in cancer
A Mahipal, M Malafa
Pharmacology & therapeutics 164, 135-143, 2016
1382016
Unexpected hepatotoxicity in a phase I study of TAS266, a novel tetravalent agonistic Nanobody® targeting the DR5 receptor
KP Papadopoulos, R Isaacs, S Bilic, K Kentsch, HA Huet, M Hofmann, ...
Cancer chemotherapy and pharmacology 75, 887-895, 2015
1332015
Phase I trial of the human double minute 2 inhibitor MK-8242 in patients with advanced solid tumors
AJ Wagner, U Banerji, A Mahipal, N Somaiah, H Hirsch, C Fancourt, ...
Journal of clinical oncology 35 (12), 1304, 2017
962017
A pilot study of sunitinib malate in patients with metastatic uveal melanoma
A Mahipal, L Tijani, K Chan, MA Laudadio, MJ Mastrangelo, T Sato
Melanoma research 22 (6), 440-446, 2012
942012
Second-line therapies in advanced biliary tract cancers
SH Tella, A Kommalapati, MJ Borad, A Mahipal
The Lancet Oncology 21 (1), e29-e41, 2020
902020
Epidermal growth factor receptor inhibitors: coming of age
A Mahipal, N Kothari, S Gupta
Cancer Control 21 (1), 74-79, 2014
852014
FGFR inhibitors in oncology: insight on the management of toxicities in clinical practice
A Kommalapati, SH Tella, M Borad, M Javle, A Mahipal
Cancers 13 (12), 2968, 2021
802021
Early stage colon cancer: Current treatment standards, evolving paradigms, and future directions
S Chakrabarti, CY Peterson, D Sriram, A Mahipal
World journal of gastrointestinal oncology 12 (8), 808, 2020
802020
Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: a propensity score matched analysis
S Yadav, H Xie, I Bin-Riaz, P Sharma, U Durani, G Goyal, B Borah, ...
European Journal of Surgical Oncology 45 (8), 1432-1438, 2019
782019
Contemporary management of localized resectable pancreatic cancer
A Kommalapati, SH Tella, G Goyal, WW Ma, A Mahipal
Cancers 10 (1), 24, 2018
782018
First-in-human phase I study of a dual mTOR kinase and DNA-PK inhibitor (CC-115) in advanced malignancy
P Munster, M Mita, A Mahipal, J Nemunaitis, C Massard, T Mikkelsen, ...
Cancer management and research, 10463-10476, 2019
722019
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20